Moxifloxacin 0.5% Eye DropsThird Party Manufacturing in India

Moxifloxacin 0.5% Eye Drops deliver the antibiotic directly to ocular tissues for the treatment of bacterial eye infections. Moxifloxacin inhibits bacterial DNA replication by targeting DNA gyrase and topoisomerase IV simultaneously. This dual-target mechanism reduces the likelihood of resistance development.

When applied topically to the eye moxifloxacin achieves high concentrations in the corneal tissue conjunctiva and aqueous humor within minutes. Its potent activity against Gram-positive bacteria including Staphylococcus aureus and Streptococcus pneumoniae makes it particularly effective for common eye infections.

Unlike some older fluoroquinolone eye drops moxifloxacin maintains good activity at neutral pH and does not require benzalkonium chloride as a preservative in certain formulations reducing the risk of corneal toxicity with prolonged use.

Therapeutic Uses

Moxifloxacin 0.5% Eye Drops are prescribed for the treatment of:

• Bacterial Conjunctivitis: Pink eye caused by susceptible Gram-positive and Gram-negative bacteria
• Corneal Ulcers: Microbial keratitis requiring intensive topical antibiotic therapy
• Post-Surgical Prophylaxis: Prevention of postoperative endophthalmitis after cataract surgery and other ophthalmic procedures
• Blepharitis: Bacterial eyelid margin inflammation

Why Manufacturers Choose Moxifloxacin Eye Drops

Moxifloxacin 0.5% Eye Drops are a high-volume ophthalmic product with strong demand from ophthalmic hospitals clinics and franchises. The product is prescribed routinely for cataract surgery prophylaxis making it a high-recurrence item. Indian manufacturers with dedicated sterile ophthalmic production lines can produce at competitive costs.

Export opportunities exist across Asia Africa and Latin America. The product is listed in WHO-recommended surgical prophylaxis protocols adding to its institutional demand.